October #128 : Cash Prizes! - by Rebecca Minnich

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Archives » POZ Magazine issues




Table of Contents
 

Here Comes the Son

Meet The Grandparents




Feet First

Attention, Class!

Flu's Clues

Gene Genies

Control Issues

Trainer's Bench-October 2006

The Big Chill

Ask The Sexpert-October 2006

Cash Prizes!

Inside Job




False Positives

Believe the Hypo

So Sue Me

Gender Bender

Hurricane Liz

The Little AIDS Club That Could

I’m Gonna Tell

Change Is Good




Editor’s Letter-October 2006

Mailbox-October 2006

Catch Of The Month-October 2006



 
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV



email print

October 2006


Cash Prizes!

by Rebecca Minnich

Will the Gates and Buffett bucks deliver a cure?

The world’s two richest men, Microsoft chair Bill Gates and investor Warren Buffett, upgraded the AIDS operating system with a huge download of cash and high-profile attention this past summer. First, in June, Gates announced plans to curb his official role at Microsoft and dedicate his full-time efforts to the Bill & Melinda Gates Foundation, which focuses on revolutionizing disease treatment in the developing world, including HIV. Weeks later, Buffett proclaimed plans to donate $30.7 billion, more than half his fortune, to the Gates Foundation, doubling its previous endowment.

First question for many Americans with HIV: How can I cash in? Answer: You probably can’t. Gates does give to a few domestic HIV causes in his native Pacific Northwest, but his focus is international. While Gates will help boost developing nations’ health systems and their ability to distribute antiretrovirals (including granting funds to the Global Fund to Fight AIDS, Tuberculosis and Malaria), the foundation has previously prioritized research for new treatments, vaccines and cures (the foundation could not comment on the exact breakdown of where the Buffet bucks would go).

Indeed, in July, Gates announced that he would give $287 million to vaccine development over the next five years. “An HIV vaccine is our best long-term hope for controlling the global AIDS epidemic,” says the foundation’s José Esparza, MD.

Will the effort finally end our 25-year wait for a vaccine? Robert Hecht, senior vice president of the International AIDS Vaccine Initiative, which will receive $24 million of the grant, says, “We haven’t had the ability to compare results we’ve needed until now, and the money will make a big difference.” Mitchell Warren, executive director of the AIDS Vaccine Advocacy Coalition, which is not slated to receive any of the grant money, says technology is a major impediment to a vaccine and that mere money is no guarantee.

“The three barriers to finding an HIV vaccine are science, science and science,” he says.

In the meantime, of course, people are still getting infected and dying daily from lack of treatment access. Even if a vaccine is developed, the 40-plus million folks who already have HIV will still need meds—likely, for the rest of their lives. Some advocates wish that Gates would put more funds into on-the-ground action. Paul Zeitz, executive director of the Global AIDS Alliance, says, “We need more than technology and cash—we need delivery teams, logistical support and an evaluation system that hold national leaders to a higher standard.” What’s the Microsoft word on that?



BUCKLING FOR A CURE

What about the legions of people who already have HIV and therefore can’t benefit from any vaccine, regardless of who funds it? After years of scientific defeats, many major researchers have shirked the quest for the cure. But in June, the American Foundation for AIDS Research (amfAR) announced that it would award $1.5 million in grants to help find the grail. “After 25 years, many people hesitate to talk about a cure,” says amfAR research director Rowena Johnston, “but we feel it’s time to take some risks and move forward.” Buzz points to virus reservoirs (places in the body where HIV hides), like the intestine, as a promising starting point. Saddle up!



[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar


    adoniz89
    san dimas
    California


    Newhopenate
    New Hope
    Pennsylvania


    sefarady
    New York
    California


    daino1972
    Columbus
    Ohio
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Are you a regular coffee drinker?
Yes
No

Survey
Pop Watch

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.